Asia Pacific

Philips and SingHealth Partner to Accelerate AI-Driven Digital Healthcare Transformation in Singapore

Strategic collaboration aims to enhance patient care by integrating AI and predictive data management, streamlining imaging workflows, and optimizing ICU capacity, with full implementation targeted by 2028....

NX Taiwan Secures TFDA Certification for Medical Device Quality Management—A First for a Japanese Company

Nippon Express (Taiwan) Co., Ltd. earns medical device QMS certification for its NEXT3 warehouse in Taoyuan, reinforcing its capabilities in compliant storage, packaging, and labeling of medical devices to meet Taiwan’s stringent quality control standards. ...

XPOVIO® Gains Public Health Insurance Coverage in Taiwan

Antengene expands access for patients with relapsed/refractory multiple myeloma....

MedTech Catapult Launches at Biopolis to Boost Singapore’s MedTech Innovation

Dr Tan See Leng officiates the launch, introducing a vital directory to connect MedTech innovators with trusted local manufacturing partners, marking a new era for Singapore’s MedTech ecosystem....

NEOM Invests in Paradromics to Advance Neurotechnology

Partnership drives innovation in brain-computer interfaces for healthcare....

Bangkok Dusit Medical Services Partners with CNN to Tackle Global Health Challenges

Collaboration aims to explore next-gen healthcare solutions through innovation and global insights. ...

“Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly”

2024 saw Japanese medtech firm Olympus receiving approval for the company’s first cloud-based AI endoscopy devices in the US and Europe, marking a significant milestone in Olympus' efforts to enhance clinical outcomes and operational efficiency in endoscopy, paving the way to launch its upcoming endoscopy solution, the “Intelligent Endoscopy Ecosystem”. The estimated revenue and annual growth rate during the fiscal year ending March 2025 of Olympus Corporation is approximately 1,009 billion yen/...

“There is a need for pharmaceutical companies to build HCP relationships, backed by scientific credibility”

Docquity, headquartered in Singapore, is Southeast Asia's largest professional network for verified healthcare professionals (HCPs), connecting over 410,000 doctors across the region. The platform enables HCPs to share clinical experiences, and engage in secure, peer-to-peer discussions. Docquity uses AI/ML to provide insights into HCP preferences, shaping personalised healthcare engagement strategies for enterprises. In an interview with BioSpectrum, Amit Vithal, Co-founder and Chief of Growth,...

Malaysia Turns Key Med Tourism Hub

Malaysia is emerging as a prominent medical tourism hub, with the sector generating revenue of $444 million (RM 2 billion) in 2023. A combination of factors is driving this growth such as including strong government support and strategic private-sector partnerships. Let's explore further....

DRG Launches Innovative TBI Test Panel at MEDLAB Dubai

The new test panel aims to revolutionize traumatic brain injury detection with advanced diagnostic capabilities....